| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1889c86c84d0f7089ceb763606c0c4db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4cec10204b2bc78246ec0e76707b32ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_06871e32ce0f0c3149618b8dc77181de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57a2ea361ab8eaf230d4aacc29a463e7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397 |
| filingDate |
2011-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8abb98115e4e8121eea97b0879a0a5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe9a216e99fdd9606a17403f86d471d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a67da80cbb82df4cb850ed7315629be3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_280af1aa7b2cee01e712236f5b4d0e8f |
| publicationDate |
2013-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013210794-A1 |
| titleOfInvention |
Nanostructured ezetimibe compositions, process for the preparation thereof and pharmaceutical compositions containing them |
| abstract |
The present invention is directed to nanostructured Ezetimibe compositions, process for the preparation thereof and pharmaceutical compositions containing them. The nanoparticles of Ezetimibe according to the invention have an average particle size of less than about 400 nm. The stable nanostructured particles of the invention are presented by increased solubility, dissolution rate, permeability and bioequivalent or enhanced biological performance compared to the marketed drug. Ezetimibe is an anti-hyperlipidemic medication that is used to lower cholesterol levels. It acts by decreasing cholesterol absorption in the intestine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110420180-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9504652-B2 |
| priorityDate |
2010-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |